Patent details

Basic Information

Publication number:

EP2081553

PCT Application Number:

US2007021477

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP078393352

PCT Publication Number:

WO2008045373

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

STABLE ANTIBODY FORMULATIONS

French Title of Invention:

FORMULATIONS STABLES COMPRENANT DES ANTICORPS

German Title of Invention:

STABILE ANTIKÖRPER-FORMULIERUNGEN

SPC Number:

Dates

Filing date:

05/10/2007

Grant date:

12/08/2020

EP Publication Date:

29/07/2009

PCT Publication Date:

17/04/2008

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/08/2020

EP B1 Publication Date:

12/08/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

05/10/2020

Expiration date:

05/10/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

05/08/2020

 

 

Name:

Amgen Inc.

Address:

One Amgen Center Drive, Thousand Oaks, CA 91320-1799, United States (US)

Inventor

1

Name:

MCAULEY, Arnold

Address:

United States (US)

2

Name:

MATSUMURA, Masazumi

Address:

United States (US)

3

Name:

REHDER, Douglas

Address:

United States (US)

Priority

1

Priority Number:

850362 P

Priority Date:

06/10/2006

Priority Country:

United States (US)

2

Priority Number:

850970 P

Priority Date:

10/10/2006

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/00; A61K 9/19; A61K 39/395; A61K 47/02; A61K 47/26;

Publication

European Patent Bulletin

Issue number:

202033

Publication date:

12/08/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages